IQVIA Holdings Inc. (NYSE: IQV) announced that its subsidiary IQVIA Inc. intends to offer €950 million in senior notes due 2033, according to a company statement.

The healthcare data and technology company plans to use proceeds from the notes offering to refinance existing debt and cover related fees and expenses. The offering remains subject to market conditions and other customary requirements.

The notes will be offered to qualified institutional buyers in the United States under Rule 144A and to non-U.S. investors outside the United States under Regulation S of the Securities Act of 1933. The securities have not been registered under U.S. securities laws.

IQVIA operates as a provider of clinical research services and healthcare intelligence to life sciences companies. The company employs approximately 93,000 people across more than 100 countries.